SCHEMBL7958673

SCHEMBL7958673

Bc1ccc2c(c1)C1(CC(c3ccccc3F)O2)NC(=S)NC1=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 6/20 0.38
AKR1B10 O60218 2/20 0.38
AKR1A1 P14550 2/20 0.38
MAPT P10636 4/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 2/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HTR6 P50406 1/20 0.32
LMNA P02545 1/20 0.32
ALOX12 P18054 1/20 0.32
HTT P42858 1/20 0.32
TDP1 Q9NUW8 2/20 0.31
POLB P06746 1/20 0.30
PKM P14618 1/20 0.30
MPI P34949 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957860 0.90 AKR1B1 (0.48) AKR1B1AKR1B10AKR1A1MAPTKDM4E
SCHEMBL1820450 0.88 AKR1B1 (0.38) AKR1B1AKR1B10AKR1A1MAPTKDM4E
SCHEMBL7957182 0.85 ALOX12 (0.39) AKR1B1AKR1B10AKR1A1MAPTKDM4E
SCHEMBL1824045 0.81 AKR1B1 (0.37) AKR1B1AKR1B10AKR1A1MAPTKDM4E
SCHEMBL1823883 0.77 AKR1B1 (0.48) AKR1B1AKR1B10AKR1A1MAPTKDM4E
SCHEMBL7971361 0.77 LMNA (0.39) MAPTKDM4EALDH1A1LMNAALOX12
SCHEMBL7956191 0.74 AKR1B1 (0.47) AKR1B1AKR1B10AKR1A1MAPT
SCHEMBL1826356 0.72 MAOB (0.44) AKR1B1AKR1B10AKR1A1ALDH1A1GAA
SCHEMBL1821671 0.72 ALOX12 (0.39) AKR1B1AKR1B10AKR1A1KDM4EHSD17B10
SCHEMBL7957786 0.72 AKR1B1 (0.55) AKR1B1AKR1B10AKR1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010021680-A2 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. (US) 2010-02-25 WO disclosed